Larimar Therapeutics logo

Larimar Therapeutics

LRMR | NASDAQ
Chart Builder DCF Calculator
$3.00
-$0.02 (-0.66%)
At close: Nov 16, 2026, 4:00 PM ET
$3.03
+$0.03 (+1.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-0.66%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
25.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #915/1021 (Top 90%)

Key Statistics

Market Data

Market Cap $311.65M
1D Range
2.89 3.29
52W Range
1.99 5.95

Valuation (TTM)

PE -1.51
PB 2.45
EV/EBITDA -0.93

Valuation (NTM)

Forward PE N/A
Forward PEG 0.05
Price Target $8.00
Loading financial charts...

Profile

Headquartered in Bala Cynwyd, Pennsylvania, Larimar Therapeutics, Inc. operates as a clinical-stage biotechnology firm. Its core mission involves crafting therapies for rare diseases, leveraging a dis...

Sector Healthcare
Industry Biotechnology
Employees 71
IPO Date Jun 19, 2014
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$7.00
Upside
+133.33%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.